However, AFP levels are elevated in only about two-thirds of patients diagnosed with HCC [4], implying that the AFP cut-off value of >400 ng/mL in European guidelines [6] cannot reliably predict HCC prognosis on its own. The gene discussed is AFP; the disease is hepatocellular carcinoma.